MTST (MetaStat) EPS (Basic): $-0.60 (TTM As of Feb. 2018)


What is MetaStat EPS (Basic)?

MetaStat MTST EPS (Basic) is $-0.60 as of Feb. 2018.

MetaStat's basic earnings per share (Basic EPS) for the three months ended in Feb. 2018 was $-0.17. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2018 was $-0.60.

MetaStat's EPS (Diluted) for the three months ended in Feb. 2018 was $-0.17. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2018 was $-0.60.

MetaStat's EPS without NRI for the three months ended in Feb. 2018 was $-0.16. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2018 was -0.70.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

MetaStat  (OTCPK:MTST) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

MetaStat EPS (Basic) Related Terms

MetaStat EPS (Basic) Historical Data

* Premium members only.

The historical data trend for MetaStat's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat EPS (Basic) Chart

MetaStat Annual Data
Trend Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.75 -4.96 -3.30 -2.10 -0.61

MetaStat Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 -0.06 -0.16 -0.21 -0.17

MetaStat EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

MetaStat's Basic EPS for the fiscal year that ended in Feb. 2018 is calculated as

Basic EPS (A: Feb. 2018 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.181-0.098)/5.425
=-0.60

MetaStat's Basic EPS for the quarter that ended in Feb. 2018 is calculated as

Basic EPS (Q: Feb. 2018 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.972-0.025)/5.924
=-0.17

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.60 mean?
MetaStat (MTST) has a EPS (Basic) of $-0.60 as of Feb. 2018. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on MetaStat and its competitors.
Is MetaStat's EPS (Basic) too high?
MetaStat's current EPS (Basic) is $-0.60.
How does MetaStat's EPS (Basic) compare to OBMP and NSPX?
MetaStat's EPS (Basic) of $-0.60 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on MetaStat and its competitors. MetaStat's current EPS (Basic) is $-0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current EPS (Basic) of $-0.60. The current EPS (Basic) is $-0.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For MetaStat (MTST), the current EPS (Basic) is $-0.60 as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.